Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa

BACKGROUND: RTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementation in endemic Africa. Model predictions of impact and cost-effectiveness of this new intervention could aid in country adoption decisions. METHODS: The impact of RTS,S was assessed in 43 countries using an...

Bibliográfalaš dieđut
Váldodahkkit:	Galactionova, K, Tediosi, F, Camponovo, F, Smith, T, Gething, P, Penny, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Elsevier 2017

Geahča maid

Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
Dahkki: Katya Galactionova, et al.
Almmustuhtton: (2021-11-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
Dahkki: Juliette Fortpied, et al.
Almmustuhtton: (2020-06-01)

RTS,S/AS01 malaria vaccine in African children.
Dahkki: Hill, A
Almmustuhtton: (2012)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
Dahkki: Corinne S. Merle, et al.
Almmustuhtton: (2023-08-01)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
Dahkki: Bejon, P, et al.
Almmustuhtton: (2009)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
Dahkki: Gosling, R, et al.
Almmustuhtton: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
Dahkki: Roly Gosling, et al.
Almmustuhtton: (2016-04-01)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
Dahkki: Hassan Mumtaz, et al.
Almmustuhtton: (2023-06-01)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
Dahkki: Duncan, C, et al.
Almmustuhtton: (2011)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
Dahkki: Alan Brooks, et al.
Almmustuhtton: (2012-01-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
Dahkki: Griffin J. Bell, et al.
Almmustuhtton: (2020-06-01)

RTS,S/AS01 vaccine (Mosquirix™): an overview
Dahkki: Matthew B. Laurens
Almmustuhtton: (2020-03-01)

Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso
Dahkki: Jean Bosco Ouédraogo, et al.
Almmustuhtton: (2023-04-01)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Dahkki: Agnandji, S, et al.
Almmustuhtton: (2012)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
Dahkki: Olotu, A, et al.
Almmustuhtton: (2016)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
Dahkki: Abdullah Nadeem, et al.
Almmustuhtton: (2023-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Dahkki: Arora N, et al.
Almmustuhtton: (2021-03-01)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Dahkki: Ranju Baral, et al.
Almmustuhtton: (2021-01-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
Dahkki: Mark E Polhemus, et al.
Almmustuhtton: (2009-07-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Dahkki: John N Waitumbi, et al.
Almmustuhtton: (2009-11-01)

Methods for costing malaria service delivery using secondary data
Dahkki: Galactionova Katva, et al.
Almmustuhtton: (2012-10-01)

RTS,S: the first malaria vaccine
Dahkki: Fidel Zavala
Almmustuhtton: (2022-01-01)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Dahkki: Agnandji, S, et al.
Almmustuhtton: (2011)

Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Dahkki: Ranju Baral, et al.
Almmustuhtton: (2021-01-01)

RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally
Dahkki: Pringle, J, et al.
Almmustuhtton: (2018)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
Dahkki: Seth Owusu-Agyei, et al.
Almmustuhtton: (2010-01-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Dahkki: Daniel Ansong, et al.
Almmustuhtton: (2011-04-01)

Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model
Dahkki: Christopher J. Genito, et al.
Almmustuhtton: (2023-08-01)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E
Dahkki: Ali, MS, et al.
Almmustuhtton: (2025)

The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya
Dahkki: Akech, S, et al.
Almmustuhtton: (2019)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Dahkki: Aroosa Younis Nadeem, et al.
Almmustuhtton: (2022-04-01)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
Dahkki: Bejon, P, et al.
Almmustuhtton: (2008)

Seasonal targeting of the RTS,S/AS01 malaria vaccine: a complementary tool but sustained funding is required
Dahkki: Silal, SP
Almmustuhtton: (2023)

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
Dahkki: Shima Mahmoudi, et al.
Almmustuhtton: (2017-09-01)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
Dahkki: Stephaney Gyaase, et al.
Almmustuhtton: (2021-01-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
Dahkki: Seth Owusu-Agyei, et al.
Almmustuhtton: (2009-10-01)

Simulation of the cost-effectiveness of malaria vaccines
Dahkki: Tediosi Fabrizio, et al.
Almmustuhtton: (2009-06-01)

What is the efficacy of the RTS,S malaria vaccine?
Dahkki: Duncan, C, et al.
Almmustuhtton: (2011)

What is the efficacy of the RTS,S malaria vaccine?
Dahkki: Duncan, C, et al.
Almmustuhtton: (2011)

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
Almmustuhtton: (2010-01-01)